Moraxella


Also found in: Medical, Wikipedia.

Moraxella

[mə′rak·sə·lə]
(microbiology)
A genus of bacteria that are parasites of mucous membranes.
Mentioned in ?
References in periodicals archive ?
Objective: To determine the prevalence of Moraxella catarrhalis in sputum cultures from patients with lower respiratory tract infection and their antimicrobial sensitivity profiles.
The major bacterial organisms infecting the lower airways of children with PBB are Haemophilus influenzae, Moraxella catarrhalis and Streptococcus pneumonia.
Staphylococcus aureus, Streptococcus pneumoniae, Haemophilus species, and Moraxella species), and hearing changes as measured by audiometry
Infectious causes of COPD exacerbation: Bacterial Non-typeable haemophilus influenzae, Moraxella catarrhalis, Streptococcus pneumoniae, Pseudomonas aeruginosa, nerobacteriaceae, Haemophilius parainfiuenzae.
Reporting out Streptococcus pneumoniae, Moraxella catarrhalis, Haemophilus influenzae, or Staphylococcus aureus from a throat specimen will lead to unnecessary antibiotic usage and, ultimately, add to the problem of resistance.
It retains activity against Moraxella catarrhalis and Haemophilus influenzae, which we think about as common pathogens in community-acquired pneumonia.
6 -- Moraxella catarrhalis -- %10 Neisseria meningitides -- -- Mycobacterium tuberculosis %1.
84 bacterias foram identificadas a genero: Pseudomonas (11), Acinetobacter (39), Pantoea (17), Aeromonas (cinco), Moraxella (quatro), Serratia (tres), Yersinia (dois), Klebsiella (um), Enterobacter (um) e Methylobacterium (um).
The bacterial species most commonly isolated from patients with RTIs include Streptococcus pneumoniae, Haemopbilus influenzae, and Moraxella catarrbalis.
Microbiologically, the organisms associated with AOM are Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and some miscellaneous respiratory bacterial pathogens.
The guidelines evaluated 19 antibiotics based on a theoretic analysis that incorporated pharmacokinetic and pharmacodynamic data from clinical trials, pathogen distribution, and in vitro activity of the various agents against the three predominant pathogens: Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis (Otolaryngol.
Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Staphylococcus aureus are among those exhibiting increased resistance to various antibacterial agents, thus limiting the available choices for effective treatment.